Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medomie Pharma is an active commercial pharmaceutical partner in Israel and the Palestinian Authority. The company specializes in bringing innovative, branded medicines, biosimilars, and niche generic products to market rapidly. It collaborates with multinational pharmaceutical companies to provide regulatory affairs services, reimbursement support, market access strategies, marketing/sales/medical affairs/compliance/pharmacovigilance/distribution for a diverse portfolio of products across multiple therapeutic areas. Recent partnerships include exclusive agreements for commercialization of ADHD medications such as Adzenys XR ODT and Cotempla XR ODT in Israel and the Palestinian Authority.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medomie Pharma.